Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.3800
+0.0400 (11.76%)
At close: Sep 17, 2026, 4:00 PM EDT
0.3764
-0.0036 (-0.95%)
After-hours: Sep 17, 2026, 7:59 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $2.11 million as of September 17, 2026. Its market cap has increased by 3.29% in one year.
Market Cap
2.11M
Enterprise Value
1.29M
1-Year Change
3.29%
Ranking
Category
Stock Price
$0.38
ChartMarket Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.54M to $2.11M, a decrease of -98.58%. That is a compound annual growth rate of -54.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 2.11M | -64.80% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.32% |
| Dec 21, 2023 | 41.98M | -71.93% |
| Dec 30, 2022 | 149.58M | 4.03% |
| Dec 31, 2021 | 143.79M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 2.43M |
| Curis | 2.34M |
| Oragenics | 2.26M |
| Virax Biolabs Group | 1.98M |
| Tessera Defense and Homeland Security | 1.92M |
| Artelo Biosciences | 1.91M |
| Decoy Therapeutics | 1.89M |
| Valion Bio | 1.85M |